BAYER AG |
Market Closed -
Other stock markets
|
After market 02:27:36 pm | |||
| 26.08 EUR | -1.44% |
|
26.16 | +0.29% |
| 10:31am | Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains | RE |
| Apr. 15 | Eurozone Industrial Production Recovery Boosts German Stocks Amid Growing Tensions in Middle East | MT |
| Sales 2024 * | 47.22B 50.22B | Sales 2025 * | 48.11B 51.17B | Capitalization | 25.99B 27.64B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.39B 2.54B | Net income 2025 * | 3.26B 3.46B | EV / Sales 2024 * | 1.25 x |
| Net Debt 2024 * | 32.87B 34.96B | Net Debt 2025 * | 29.82B 31.71B | EV / Sales 2025 * | 1.16 x |
| P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
7.9
x | Employees | 96,931 |
| Yield 2024 * |
1.52% | Yield 2025 * |
1.5% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
More news
| 1 day | -0.56% | ||
| 1 week | -4.02% | ||
| Current month | -7.51% | ||
| 1 month | +0.31% | ||
| 3 months | -21.58% | ||
| 6 months | -39.68% | ||
| Current year | -21.81% |
1 week
25.92
28.25
1 month
25.7128.94
Current year
24.9636.09
1 year
24.9661.91
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
| Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 26.08 | -1.44% | 3 296 976 |
| 24-04-15 | 26.46 | -1.87% | 4,111,723 |
| 24-04-12 | 26.96 | -0.20% | 3,638,040 |
| 24-04-11 | 27.02 | -2.01% | 3,313,778 |
| 24-04-10 | 27.58 | +0.66% | 3,583,402 |
Delayed Quote Xetra, April 16, 2024 at 07:45 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.46
EUR
Average target price
37.62
EUR
Spread / Average Target
+42.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.81% | 27.64B | |
| +28.79% | 676B | |
| +23.88% | 559B | |
| -5.84% | 356B | |
| +15.75% | 320B | |
| +4.32% | 286B | |
| +3.30% | 213B | |
| +0.13% | 207B | |
| -8.96% | 199B | |
| -10.00% | 147B |
- Stock Market
- Equities
- BAYN Stock
